Sigma Aldrich Applies to Bulk-Produce Controlled Drugs
Published Date: 3/13/2025
Notice
Summary
Sigma Aldrich Research Biochemicals Inc. wants to become a big-time maker of certain controlled substances. This means they’ll be officially allowed to produce these drugs in large amounts, which could impact researchers and companies relying on these materials. Keep an eye out for updates on their approval and any related deadlines or fees.
No Economic Impacts Identified for this Document
Your PRIA Score
Personalized for You
How does this regulation affect your finances?
Sign up for a PRIA Policy Scan to see your personalized alignment score for this federal register document and every other regulation we track. We analyze your financial profile against policy provisions to show you exactly what matters to your wallet.
Key Dates
Department and Agencies
Take It Personal
Get Your Personalized Policy View
Start a Free Government Policy Watch to see how policy affects your household, then upgrade to PRIA Full Coverage for year-round monitoring.
Already have an account? Sign in